Brief: Synact Pharma Board, Management Buy Shares Worth Over SEK 1 Mln

SynAct Pharma AB

26/06/2025 07:26

June 26 (Reuters) - SynAct Pharma AB SYNACT.ST:

A MAJORITY OF SYNACT PHARMA’S BOARD AND MANAGEMENT HAVE ACQUIRED SHARES WITH A VALUE OF MORE THAN SEK 1 MILLION

CHAIRMAN OF BOARD, ANDERS KRONBORG, AND BOARD MEMBER STEN R. SÖRENSEN HAVE ACQUIRED IN TOTAL 9,198 NUMBER

CEO JEPPE ØVLESEN, CFO BJÖRN WESTBERG, CSO THOMAS JONASSEN, AND COO THOMAS BOESEN, HAVE ACQUIRED 48,747 SHARES

RELATED PARTIES, TO MANAGEMENT, HAVE ACQUIRED 3,580 SHARES

Source text: ID:nMFNsmH6s

Further company coverage: SYNACT.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))